MoneyWorks4Me

Lyka Labs informs about outcome of board meeting

25 Nov 2017 Evaluate

Lyka Labs has informed about the Board of Directors at their meeting held on 24th November, 2017 has considered un- audited standalone financial results for the second quarter and six months ended 30th September, 2017.

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1737.00
Dr. Reddys Labs. 1237.20
Cipla 1324.90
Lupin 1942.60
Zydus Lifesciences 1118.45
View more..